---
title: Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness Practice
nct_id: NCT03924531
overall_status: COMPLETED
phase: NA
sponsor: University of California, Los Angeles
study_type: INTERVENTIONAL
primary_condition: Health Behavior Modification Using Mindfulness
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03924531.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03924531"
ct_last_update_post_date: 2025-12-22
last_seen_at: "2026-05-12T06:24:37.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness Practice

**NCT ID:** [NCT03924531](https://clinicaltrials.gov/study/NCT03924531)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 36
- **Lead Sponsor:** University of California, Los Angeles
- **Conditions:** Health Behavior Modification Using Mindfulness
- **Start Date:** 2017-08-01
- **Completion Date:** 2019-03-31
- **CT.gov Last Update:** 2025-12-22

## Brief Summary

Adherence is a major problem for the approximately one-third of Americans over the age of 20 who suffer from Hypertension (HTN). Hypertension can be controlled through medication adherence and lifestyle modifications (diet and exercise). However, nearly 50% of those with HTN report poor adherence to their antihypertensive medications, lifestyle changes, or both as primary reasons for failing to control their blood pressure. Currently, behavioral interventions are limited to providing education or reminding individuals to take better care of themselves by starting and adhering to proper diet and exercise program. Given the lack of adherence reported, education and reminders alone may not be sufficient to promote health behavior change. Interventions that appeal to individual's internal drive may be more effective, given that behavior adoption and maintenance are usually associated with intrinsic motivation and volition. Mindfulness practice is an intervention that shows promise in changing lifestyle behaviors. The purpose of this study is to investigate the use of UCLA's Mindful Awareness Program (UCLAMAP) on promoting self-management behaviors, specifically adherence to medication, diet, and exercise for those individuals with HTN. We will randomize 52 individuals with HTN who have difficulty with adherence to antihypertensive medications and lifestyle changes to the intervention group or the attention-control group. The intervention includes six sessions of the mindfulness training through UCLA's Mindful Awareness Research Center (MARC).

## Eligibility

- **Minimum age:** 21 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* over 21 years of age
* able to understand and speak English
* self-report of having difficulty with a healthy diet and engaging in regular physical activity.

Exclusion Criteria:

* On chemotherapy for cancer treatment
* Current substance abuse disorder (i.e., drugs, alcohol).
* Current diagnoses of Post-traumatic stress disorders, severe anxiety, or severe depression.
* On hemodialysis.
* Pregnant. (Pregnant women may develop Preeclampsia, which is a pregnancy complication characterized by high blood pressure)
```

## Arms

- **Mindful Awareness Program** (EXPERIMENTAL) — The group that received mindfulness training.
- **Health Promotion Program** (ACTIVE_COMPARATOR) — The group that received the health information.

## Interventions

- **Mindful Awareness Program** (BEHAVIORAL) — 2-hour mindfulness training for 6 weeks.
- **Health Promotion Program** (BEHAVIORAL) — Health Promotion Program

## Primary Outcomes

- **Diet** _(time frame: up to 12 weeks)_ — 21 item questionnaire called Rapid Eating and Activity Assessment for Patients (REAP). Various questions related to food choices. The answer choices were rarely, sometimes, and often for each food questions.
- **Exercise** _(time frame: up to 12 weeks)_ — The instrument used was called the Brief Physical Assessment. The is a 6 item weekly questionnaire that asked the minutes the participants performed a particular exercise behavior.
- **Blood pressure medication adherence** _(time frame: up to 12 weeks)_ — The instrument used was called the Brief Medication Questionnaire (BMQ).The tool includes a 5-item Regimen Screen that asks patients how they took each medication in the past week, a 2-item Belief Screen that asks about drug effects and bothersome features, and a 2-item Recall Screen about potential difficulties remembering. We collected the number of missed medication days.

## Secondary Outcomes

- **Blood pressure measurements** _(time frame: up to 12 weeks)_

## Locations (1)

- UCLA, Los Angeles, California, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.ucla|los angeles|california|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03924531.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03924531*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*